Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause
Author(s) -
Mariane Cristina Flores-Nascimento,
Fernanda Andrade Orsi,
Ana Paula Hitomi Yokoyama,
Fernanda G. Pereira,
Irene LorandMetze,
Erich Vinícius De Paula,
Vagner Castro,
Joyce Maria AnnichinoBizzacchi
Publication year - 2011
Publication title -
blood coagulation and fibrinolysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.376
H-Index - 71
eISSN - 1473-5733
pISSN - 0957-5235
DOI - 10.1097/mbc.0b013e32834d0c81
Subject(s) - platelet , medicine , coagulation , platelet activation , coagulation disorder , annexin , coagulation testing , gastroenterology , cardiology , surgery , pathology , immunology , flow cytometry
Scott syndrome is a rare bleeding disorder due to an impaired exposure of phosphatidilserine on the platelet membrane, compromising the platelet procoagulant activity, thrombin generation and, thus, the clot formation. We report a case of a 17-year-old female adolescent with bleeding episodes of unknown cause. She had normal coagulation, but altered platelet aggregation under arteriolar flow, indicating platelet dysfunction. Furthermore, the expression of Annexin V was markedly reduced and the diagnosis of Scott syndrome was established. She was treated with platelet transfusions and demonstrated a clinical improvement. Scott syndrome may be investigated in cases with bleeding history and normal coagulation tests.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom